π¬ AI making new viruses? Traders are cautious.
Artificial intelligence is now capable of designing novel viruses that have never been observed in nature. This capability was reported by various research bodies in the field of bioinformatics. The probability assigned by traders to this risk remains low, at only 10% as of the latest market analysis. This development highlights the dual-use potential of advanced AI in biological research. Further regulatory discussions are expected as the technology advances.